Cargando…

Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice

The nucleoprotein (NP) is a highly conserved internal protein of the influenza virus, a major target for universal influenza vaccine. Our previous studies have proven NP-based subunit vaccine can provide partial protection in mice. It is reported that the protein transduction domain (PTD) TAT protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Yuan, Li, BeiBei, Zhou, Linting, Luo, Jian, Liu, Xueying, Wang, Shilei, Lu, Qun, Tan, Wensong, Chen, Ze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284974/ https://www.ncbi.nlm.nih.gov/pubmed/32811334 http://dx.doi.org/10.1080/22221751.2020.1812436

Ejemplares similares

Immunization with DNA prime-subunit protein boost strategy based on influenza H9N2 virus conserved matrix protein M1 and its epitope screening
por: Liu, Fen, et al.
Publicado: (2020)

MiRNA Targeted NP Genome of Live Attenuated Influenza Vaccines Provide Cross-Protection against a Lethal Influenza Virus Infection
por: Gao, Feixia, et al.
Publicado: (2020)

An antigenic epitope of influenza virus nucleoprotein (NP) associated with polymeric forms of NP
por: Prokudina, Elena N, et al.
Publicado: (2008)

Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
por: Berthoud, Tamara K., et al.
Publicado: (2011)

Interaction of Polymerase Subunit PB2 and NP with Importin α1 Is a Determinant of Host Range of Influenza A Virus
por: Gabriel, Gülsah, et al.
Publicado: (2008)

Role of influenza A virus NP acetylation on viral growth and replication
por: Giese, Sebastian, et al.
Publicado: (2017)

Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions
por: Noton, Sarah L., et al.
Publicado: (2007)

AuNP-M2e + sCpG vaccination of juvenile mice generates lifelong protective immunity to influenza A virus infection
por: Bimler, Lynn, et al.
Publicado: (2019)

Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats
por: Wang, Wenling, et al.
Publicado: (2019)

Enhancement of DNA Vaccine-induced Immune Responses by Influenza Virus NP Gene
por: Choi, So Young, et al.
Publicado: (2009)

Modeling the Influenza A NP-vRNA-Polymerase Complex in Atomic Detail
por: Miner, Jacob C., et al.
Publicado: (2021)

Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
por: Powell, Timothy J., et al.
Publicado: (2013)

Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses
por: Kwak, Chaewon, et al.
Publicado: (2021)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
por: McMahon, Meagan, et al.
Publicado: (2019)

Transmembrane domain of IFITM3 is responsible for its interaction with influenza virus HA(2) subunit
por: Xu, Wang, et al.
Publicado: (2022)

Characterization of Potent Fusion Inhibitors of Influenza Virus
por: Rowse, Michael, et al.
Publicado: (2015)

Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection
por: Koutsonanos, Dimitrios G., et al.
Publicado: (2012)

A plant‐produced influenza subunit vaccine protects ferrets against virus challenge
por: Mett, Vadim, et al.
Publicado: (2008)

Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza
por: Tjärnhage, Elias, et al.
Publicado: (2023)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
por: Asthagiri Arunkumar, Guha, et al.
Publicado: (2019)

NXT1, a Novel Influenza A NP Binding Protein, Promotes the Nuclear Export of NP via a CRM1-Dependent Pathway
por: Chutiwitoonchai, Nopporn, et al.
Publicado: (2016)

The structure of the nucleoprotein of Influenza D shows that all Orthomyxoviridae nucleoproteins have a similar NP(CORE), with or without a NP(TAIL) for nuclear transport
por: Donchet, Amélie, et al.
Publicado: (2019)

Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli
por: Wang, Wenling, et al.
Publicado: (2012)

Preclinical Study of ZSP1273, a Potent Antiviral Inhibitor of Cap Binding to the PB2 Subunit of Influenza A Polymerase
por: Chen, Xiaoxin, et al.
Publicado: (2023)

Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1
por: Zhirnov, Oleg P., et al.
Publicado: (2007)

Immunogenicity and safety of subunit influenza vaccines in pregnant women
por: Kostinov, Mikhail P., et al.
Publicado: (2018)

Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement
por: Khalaj‐Hedayati, Atin, et al.
Publicado: (2019)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
por: Lillie, Patrick J., et al.
Publicado: (2012)

Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
por: Kim, So-Hee, et al.
Publicado: (2013)

Immunogenicity and Protective Efficacy of a Dual Subunit Vaccine Against Respiratory Syncytial Virus and Influenza Virus
por: Park, Min-Hee, et al.
Publicado: (2012)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
por: Liu, Heng, et al.
Publicado: (2012)

Protection against Multiple Subtypes of Influenza Viruses by Virus-Like Particle Vaccines Based on a Hemagglutinin Conserved Epitope
por: Chen, Shaoheng, et al.
Publicado: (2015)

Expression of Influenza M2e-NP Recombinant Fusion Protein in Escherichia coli BL21 (DE3) and Its Binding to Antibodies
por: Tan, Mei Peng, et al.
Publicado: (2022)

Altered Signal Transduction in the Immune Response to Influenza Virus and S. pneumoniae or S. aureus Co-Infections
por: Wilden, Janine J., et al.
Publicado: (2021)

Potent Neutralization of Influenza A Virus by a Single-Domain Antibody Blocking M2 Ion Channel Protein
por: Wei, Guowei, et al.
Publicado: (2011)

Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains
por: Turner, Hannah L., et al.
Publicado: (2019)

Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP
por: Babin, Cindy, et al.
Publicado: (2013)

Inhibition of Influenza A Virus Replication by TRIM14 via Its Multifaceted Protein–Protein Interaction With NP
por: Wu, Xiangwei, et al.
Publicado: (2019)

Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8(+) T Cell Epitopes
por: Soema, Peter C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_53jsq7atlvgor9qalmpgtv0jfc